India has rejected a drug patent application of a US multi-national pharma company, Abbot Laboratories, paving way for easy access to an important life-saving medication for HIV patients across the globe. Indian Express
India has rejected a drug patent application of a US multi-national pharma company, Abbot Laboratories, paving way for easy access to an important life-saving medication for HIV patients across the globe. Indian Express
Partner with us now to build
a more just and equitable
medicine system for all.